$2.5B in outsourcing headed India's way

Subcontinent rising: A new report on India's pharmaceuticals industry predicts it will take over about $2.5 billion in drugmakers' outsourcing by 2012. As companies in the EU and U.S. look for lower-cost manufacturing and R&D, India will get an influx of new work, according to the report from Zinnov Management Consulting.

The country has certainly done a lot to encourage that growth. Besides a rich talent pool and a number of pharma-educational institutes, the Indian government has also started offering tax incentives to drugmakers and set up some necessary legal infrastructure, the report says. "India has the potential to become one of the key global pharmaceutical players and also become the backbone of off-shored services in Pharmaceuticals," Zinnov's CEO said.

- read the story at India Infoline

Suggested Articles

With a brand new approval for Adakveo under its belt, Novartis Sunday flaunted an analysis showing the drug could cut patient hospitalizations by 40%.

BeiGene only just won its first Brukinsa nod in MCL. But it’s already pushing to join the CLL field, and Sunday it rolled out more data.

How long can one infusion of CAR-T drug Yescarta continue helping patients with refractory large B-cell lymphoma? Pretty long, Gilead showed Saturday.